Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs
Geraint Davies, Martin J. Boeree, Dave Hermann, Michael Höelscher
PLoS Medicine · 2019-07
Abstract
Geraint Davies and colleagues discuss the potential for innovative early-phase clinical trial methods and technologies to reduce risk and speed up drug development for tuberculosis.
MeSH terms
- Extensively drug-resistant tuberculosis
- Tuberculosis
- Drug
- Phase (matter)
- Medicine
- Pharmacology